Antimicrobial Effectiveness Testing of Resorbable Electrospun Fiber Matrix per United States Pharmacopeia (USP)
Cureus · 06.12.2023
DOI: 10.7759/cureus.50055 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cureus, erschienen am 06.12.2023. Verfasst von Emily Sallade und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research, Acera Surgical, Inc., St. Louis, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Contamination of surgical, traumatic, and chronic wounds with microorganisms presents a challenge to successful wound healing. In the present in vitro study, a synthetic electrospun fiber matrix (SEFM) cleared for use in the management of chronic, surgical, and traumatic wounds underwent USP (United States Pharmacopeia) Antimicrobial Effectiveness Testing to determine its in vitro effectiveness against various microorganisms commonly found in non-healing wounds. The SEFM was tested in both sheet (s-SEFM) and micronized form (m-SEFM) against Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Aspergillus brasiliensis, Candida albicans, Proteus mirabilis, and Enterococcus faecalis. Testing was performed per the USP standard on days 7, 14, and 28. Both the s-SEFM and m-SEFM met the USP acceptance criteria for all microorganisms. The results obtained for s-SEFM demonstrated >1-log10 reduction against E. coli, S. aureus, P. aeruginosa, P. mirabilis, E. faecalis, and C. albicans at day 7; >3-log10 reduction with no detection of these microbes at days 14 and 28, and no increase from initial inoculum at days 7, 14, and 28 against A. brasiliensis. The results obtained for m-SEFM demonstrated >3-log10 reduction with no detectable microorganisms at day 7. The results observed in this study indicate that the SEFM is effective in vitro at inhibiting bacterial and fungal growth and colonization per USP testing.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Research, Acera Surgical, Inc., St. Louis, USA.
- Research and Development, Acera Surgical, Inc., St. Louis, USA.
Zitieren
APA
Sallade, E., Grimes, D., Jeng, L., & MacEwan, M. R. (2023). Antimicrobial Effectiveness Testing of Resorbable Electrospun Fiber Matrix per United States Pharmacopeia (USP). Cureus. https://doi.org/10.7759/cureus.50055
Vancouver
Sallade E, Grimes D, Jeng L, MacEwan MR. Antimicrobial Effectiveness Testing of Resorbable Electrospun Fiber Matrix per United States Pharmacopeia (USP). Cureus. 2023. doi:10.7759/cureus.50055
BibTeX
@article{Sallade2023,
author = {Sallade, Emily and Grimes, Derayvia and Jeng, Lily and MacEwan, Matthew R},
title = {Antimicrobial Effectiveness Testing of Resorbable Electrospun Fiber Matrix per United States Pharmacopeia (USP)},
journal = {Cureus},
year = {2023},
doi = {10.7759/cureus.50055}
}
EUVIMED